According to Pharm Aid contraindicated prescribing is responsible for the withdrawal of these two drugs from the market. You can bet the trial lawyers are interested and they’ll be going after the drug companies, not the doctors. The drug companies will also take the public relations hit. Contraindicated prescribing not only causes direct harm to patients but also, by causing good drugs to be yanked, deprives many patients of beneficial therapies.
I’ve previously blogged this very point here and here and discussed it in the Medscape Roundtable here.